{{Rsnum
|rsid=6502867
|Gene=NLRP1
|Chromosome=17
|position=5517008
|Orientation=plus
|GMAF=0.1483
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NLRP1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 40.7 | 53.1
| HCB | 0.0 | 4.4 | 95.6
| JPT | 0.0 | 8.0 | 92.0
| YRI | 0.0 | 4.8 | 95.2
| ASW | 1.8 | 17.5 | 80.7
| CHB | 0.0 | 4.4 | 95.6
| CHD | 0.0 | 9.2 | 90.8
| GIH | 0.0 | 23.8 | 76.2
| LWK | 0.0 | 10.9 | 89.1
| MEX | 5.2 | 36.2 | 58.6
| MKK | 1.3 | 16.8 | 81.9
| TSI | 2.9 | 44.1 | 52.9
| HapMapRevision=28
}}linked to generalized vitiligo

{{PMID|17637824}} Individuals carrying high-risk alleles of both [[rs6502867]] and [[rs2670660]] had an odds ratio of 4.20 compared with individuals carrying a high-risk allele from only one signal.

{{PMID Auto
|PMID=19727120
|Title=Fine-Mapping of Vitiligo Susceptibility Loci on Chromosomes 7 and 9 and Interactions with NLRP1 (NALP1)
|OA=1
}}

{{PMID Auto
|PMID=21149496
|Title=NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis.
}}

{{PMID Auto
|PMID=21331694
|Title=Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease.
}}

{{PMID Auto
|PMID=21976003
|Title=NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in han chinese.
}}

{{PMID Auto
|PMID=23773036
|Title=Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}